Rivaroxaban needs to be stopped for a few days before surgery

If anticoagulant therapy must be discontinued to reduce the risk of bleeding during surgery or other procedures, Rivaroxaban should be discontinued at least24 hours before surgery to reduce the risk of bleeding. When deciding whether to delay surgery until 24 hours after the last dose of rivaroxaban, the increased risk of bleeding should be weighed against the urgency of intervention. After surgery or other procedures, rivaroxaban should be restarted once hemostasis has been achieved, taking into account the short onset of action. If oral medications cannot be taken during or after surgery, injectable anticoagulants may be considered.

Rivaroxaban, the active ingredient in rivaroxaban, is a "factor Xa inhibitor," which means it blocks factorXa, an enzyme involved in the generation of thrombin. Thrombin is central to the blood clotting process, and by blocking Factor Rivaroxaban should not be used in patients with bleeding or in patients with liver disease or an increased risk of bleeding, nor should it be used with any other anticoagulant medication, except in specific circumstances. Rivaroxaban should not be used in pregnant or breastfeeding women.

RivaroxabanThe original drug is already on the market in China and can be found under Class B medical insurance. SpecificationsThe price of 10mg*5 tablets is around RMB 100. This drug may be sold in domestic pharmacies or hospitals. The Turkish version of rivaroxabanoriginal drug marketed overseas, specifications10mg*10 tablets, is priced around RMB 170 (the price may fluctuate due to exchange rates). The ingredients of the original rivaroxaban drug sold domestically and abroad are basically the same. Currently, there are no generic drugs produced in other countries on the market overseas.